Polynovo Ltd
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more
Polynovo Ltd - Asset Resilience Ratio
Polynovo Ltd (PNV) has an Asset Resilience Ratio of 5.46% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2025)
This chart shows how Polynovo Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Polynovo Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$6.91 Million | 5.42% |
| Short-term Investments | AU$50.00K | 0.04% |
| Total Liquid Assets | AU$6.96 Million | 5.46% |
Asset Resilience Insights
- Limited Liquidity: Polynovo Ltd maintains only 5.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Polynovo Ltd Industry Peers by Asset Resilience Ratio
Compare Polynovo Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Polynovo Ltd (2000–2025)
The table below shows the annual Asset Resilience Ratio data for Polynovo Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-06-30 | 5.46% | AU$6.96 Million | AU$127.41 Million | -16.88pp |
| 2024-06-30 | 22.34% | AU$24.29 Million | AU$108.72 Million | +22.29pp |
| 2023-06-30 | 0.05% | AU$50.00K | AU$92.62 Million | -0.09pp |
| 2022-06-30 | 0.14% | AU$50.00K | AU$34.97 Million | +0.01pp |
| 2021-06-30 | 0.13% | AU$50.00K | AU$38.34 Million | 0.00pp |
| 2020-06-30 | 0.13% | AU$50.00K | AU$37.86 Million | -0.05pp |
| 2019-06-30 | 0.18% | AU$50.00K | AU$28.23 Million | -63.70pp |
| 2018-06-30 | 63.88% | AU$19.05 Million | AU$29.82 Million | +63.46pp |
| 2017-06-30 | 0.41% | AU$50.00K | AU$12.06 Million | +0.10pp |
| 2016-06-30 | 0.31% | AU$50.00K | AU$16.02 Million | -0.43pp |
| 2015-06-30 | 0.74% | AU$60.00K | AU$8.13 Million | +0.10pp |
| 2014-06-30 | 0.64% | AU$60.00K | AU$9.41 Million | -12.82pp |
| 2013-06-30 | 13.46% | AU$1.16 Million | AU$8.62 Million | -7.42pp |
| 2012-06-30 | 20.88% | AU$1.86 Million | AU$8.91 Million | -11.06pp |
| 2011-06-30 | 31.94% | AU$3.76 Million | AU$11.77 Million | +31.54pp |
| 2010-06-30 | 0.40% | AU$60.00K | AU$15.02 Million | -86.21pp |
| 2000-06-30 | 86.61% | AU$10.36 Million | AU$11.96 Million | -- |